Author:
Obianom O. N.,Thway Theingi M.,Schrieber S. J.,Okusanya O. O.,Wang Y. M.,Huang S. M.,Zineh I.
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Thway TM. Fundamentals of large-molecule protein therapeutic bioanalysis using ligand-binding assay. Bioanalysis. 2016;8(1):11–7.
2. O’Hara DM, Theobald V, Egan AC, Usansky J, Krishna M, TerWee J, et al. Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents. AAPS J. 2012;14(2):316–28.
3. U.S. Food and Drug Administration’s Guidance for Industry titled Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product published on December 2016.
4. U.S. Food and Drug Administration’s Guidance for Industry titled Bioanalytical Method Validation published on May 2018.
5. Marini JC, Anderson M, Cai XY, Chappell J, Coffey T, Gouty D, et al. Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessments. AAPS J. 2014;16(6):1149–58.